Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-19-023769
Filing Date
2019-11-15
Accepted
2019-11-15 17:15:42
Documents
1
Period of Report
2019-11-15

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a1019_actiniumpharma.htm PRE 14A 650054
  Complete submission text file 0001213900-19-023769.txt   651158
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36374 | Film No.: 191225336
SIC: 2834 Pharmaceutical Preparations